Rhythm Pharmaceuticals' Series C Round

Rhythm Pharmaceuticals raised a round of funding on July 30, 2013.

Rhythm Pharmaceuticals is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm is developing the ghrelin peptide agonist, RM-131, for the trea…

Articles about Rhythm Pharmaceuticals' Series C Round: